BTK Inhibitors in the Treatment of MS MStranslate December 12, 2023 Clinical Trials, Research, Treatments What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B...
Clemastine Repairs Damage In Multiple Sclerosis MStranslate July 4, 2023 Clinical Trials, Neuroimaging, Remyelination Research Summary: MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial Remyelination or myelin repair is...
Research Reflections: Siponimod Trial Results MStranslate November 21, 2019 Clinical Trials, Research, Treatments 1 Comment In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod)....
ECTRIMS 2019: Final Thoughts From Stockholm MStranslate September 13, 2019 Dr Travis Stiles, ECTRIMS, Research ECTRIMS 2019 has officially ended. It is safe to say that it was a huge three days and I am exhausted! I really hope that you have enjoyed the...
Do We Need Clinical Trials for MS Lifestyle Treatments? MStranslate August 30, 2017 Lifestyle, Opinion, Treatments 1 Comment We have been discussing lifestyle factors, such as diet and exercise, a lot recently on MStranslate. This has been presented both in terms of the...
MIS416 Multiple Sclerosis Trial Results MStranslate June 28, 2017 MIS416, Research, Treatments On Tuesday, Innate Immunotherapeutics released a report outlining the first set of results from their Phase 2b trial on the use of their compound,...
Multiple Sclerosis Clinical Trial Update: Laquinimod MStranslate May 9, 2017 Clinical Trials, Laquinimod, Research What is laquinimod? Laquinimod is a once-daily oral medication that has been developed and tested for the treatment of relapsing-remitting multiple...
High-dose Biotin Clinical Trial Results MStranslate September 13, 2016 Biotin, Clinical Trials, Research, Treatments 1 Comment Research Summary: MD1003 (high-dose biotin) for the treatment of multiple sclerosis: A randomised, double-blind, placebo-controlled study The...
MOMENTUM Phase II Trial Results MStranslate August 22, 2016 Clinical Trials, Fingolimod, Research The background Fingolimod was approved in 2010 and became the first oral drug for the treatment of relapsing-remitting MS (RRMS). It has proven to...
Multiple Sclerosis Research: Dr Leigh Charvet MStranslate May 9, 2016 AAN, Clinical Trials, Cognition, Conferences, Research, Symptoms INTERVIEW WITH DR LEIGH CHARVET – NYU LANGONE MULTIPLE SCLEROSIS COMPREHENSIVE CARE CENTER BD: Brett Drummond, MStranslate LC: Dr. Leigh...
